Chris Taylor | Vice President of Investor Relations and Corporate Communications |
Dr. Laurence Cooper | Chief Executive Officer |
Dr. David Mauney | President |
Satyavrat Shukla | Chief Financial Officer |
David Novak | Raymond James |
Thomas Flaten | Lake Street Capital |
Sean Lee | H.C. Wainwright |
Good afternoon, ladies and gentlemen. Thank you for standing by and welcome to the Ziopharm Oncology Third Quarter 2019 Results Call. At this time all participants are in a listen only mode. Later we will conduct the question-and-answer session and instructions will follow at that time. [Operator instructions] As a reminder, this call may be recorded.